SCHEMBL3410595

SCHEMBL3410595

CCOC(=O)Cc1ccc(OC)c(-c2ccc(-c3ncc(F)cn3)cc2CNC(C)C(=O)OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 13/20 0.42
DRD2 P14416 1/20 0.37
PTGDR Q13258 2/20 0.36
CYP3A4 P08684 1/20 0.36
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
TBXA2R P21731 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
P2RX7 Q99572 1/20 0.34
CASR P41180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL152507 0.86 PTGDR2 (0.42) PTGDR2DRD2PTGDRCYP3A4JAK2
SCHEMBL137315 0.85 PTGDR2 (0.46) PTGDR2PTGDRCYP3A4JAK2JAK3
SCHEMBL136352 0.83 PTGDR2 (0.53) PTGDR2PTGDRCYP3A4TBXA2R
SCHEMBL151574 0.80 PTGDR2 (0.49) PTGDR2DRD2PTGDRCYP3A4
SCHEMBL153704 0.78 PTGDR2 (0.51) PTGDR2DRD2PTGDRCYP3A4JAK2
SCHEMBL137823 0.75 PTGDR2 (0.72) PTGDR2PTGDRCYP3A4TBXA2R
SCHEMBL137811 0.75 PTGDR2 (0.56) PTGDR2PTGDRCYP3A4JAK2JAK3
SCHEMBL137311 0.74 PTGDR2 (0.63) PTGDR2PTGDRCYP3A4TBXA2R
SCHEMBL151818 0.73 PTGDR2 (0.51) PTGDR2DRD2PTGDRCYP3A4JAK2
SCHEMBL138884 0.72 PTGDR2 (0.49) PTGDR2PTGDRTBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257524-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 EP disclosed
WO-2009099902-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed